上海市女性乳腺癌流行现况、回顾与比较分析

doi:10.16139/j.1007-9610.2019.05.011

摘要/Abstract

摘要： 目的：描述2002—2015年上海市女性乳腺癌发病和死亡的近期特征和趋势变化,为探寻病因学研究线索,制定和评估乳腺癌预防、研究与控制的规划和措施提供依据。方法：根据上海市恶性肿瘤病例报告登记系统收集的女性乳腺癌发病资料,描述2013—2015年期间的发病和死亡概况,并与2018年的国际数据进行比较分析,对年龄分布、诊断依据、病理类型、诊断时期别等特征进行具体描述,分析2002—2015年发病和死亡的标率与年龄别率变化趋势。结果：2013—2015年,乳腺癌仍居上海全市女性恶性肿瘤的发病首位和死亡癌谱的第4位,年均新诊断5 293例,占全部女性恶性肿瘤的15.82%,发病粗率为73.34/10万,发病标率为38.45/10万,死亡发病数比为0.27;因乳腺癌死亡的女性年均1 448人,占全部女性癌症死因的9.51%,死亡粗率为20.06/10万,死亡标率7.42/10万。发病粗率和死亡粗率高于世界、东亚地区和中国平均水平,低于美国,而死亡标率低于所有这些地区。20~59岁各组年龄别发病率随着年龄的增长而上升,55~74岁各组的率值相近,75岁及以后随年龄的增长出现下降;所研究各组年龄别死亡率随着年龄的增长而上升。新发病例的病理诊断比例为94.39%,诊断时期别的Ⅰ期比例为29.42%,不详比例为30.82%。2002—2015年,上海市女性乳腺癌发病标率呈现持续上升的趋势,死亡标率总体显示平稳趋势。结论：2002—2015年间,上海女性乳腺癌发病标率持续增高。死亡标率总体显示平稳趋势,提示治疗有效,生存状况改善。

关键词: 女性, 乳腺癌, 发病, 死亡, 流行病学

Abstract: Objective To analyze the current incidence and mortality of female breast cancer in Shanghai during the period 2002-2015 and to provide the reference for research on breast cancer prevention and control. Methods The data of female cases with breast cancer were collected by the Shanghai Cancer Registry. The incidence and mortality of female breast cancer in Shanghai between 2013 and 2015 were compared with those in international study in 2018. The age distribution, basis of diagnosis, pathological classification and diagnostic stage were studied. Both standardized rates and age-specific rates of incidence and mortality of breast cancer between 2002 and 2015 were analyzed. Results Breast cancer incidence lists the first rank and the mortality of breast cancer lists the 4th rank in female cancer in Shanghai between 2013 and 2015. Averagely, 5 293 female cases with breast cancer were diagnosed each year between 2013 and 2015 in Shanghai which accounted for 15.82% of total female cancer. The crude rate of incidence was 73.34 per 100 000 and standar-dized rate was 38.45 per 100 000 with ratio of mortality-incidence 0.27. There were 1 448 cases of death due to breast cancer each year accounting for 9.51% of all female cancer death. The crude rate of mortality was 20.06 per 100 000 with standardized rate 7.42 per 100 000. The crude rate of incidence and mortality in Shanghai were higher than that in the world, Eastern Asia, China but lower than in USA. Standardized mortality of breast cancer in Shanghai, however, was lower than that in all including Eastern Asia, USA, China and the world. The age-specific incidences of breast cancer increased with age from 20 to 59 years old with similar incidence in the groups between 55 to 74 years old, and decreased with age increasing from 75 years old. The age-specific mortality increased with age from 20 to 85 years and older. There were 94.39% of new cases of breast cancer with pathological diagnosis, 29.42% of cases on stage one and 30.82% of cases with incomplete data. Between 2002 and 2015, the age-standardized incidence of female breast cancer in Shanghai showed the trend increasing constantly and the trend of mortality without change. Conclusions The age-standardized incidence of female breast cancer increased in Shanghai between 2002 and 2015. The mortality of breast cancer without change suggests effective treatment and improvement of survival.

Key words: Female, Breast Cancer, Incidence, Mortality, Epidemiology

中图分类号:

R737.9

吴春晓, 顾凯, 王春芳, 彭鹏, 龚杨明, 施亮, 向詠梅, 庞怡, 鲍萍萍. 上海市女性乳腺癌流行现况、回顾与比较分析[J]. 外科理论与实践, 2019, 24(05): 421-427.

WU Chunxiao, GU Kai, WANG Chunfang, PENG Peng, GONG Yangming, SHI Liang, XIANG Yongmei, PANG Yi, BAO Pingping. Incidence of female breast cancer in Shanghai: current evidence and a comparative retrospective study[J]. Journal of Surgery Concepts & Practice, 2019, 24(05): 421-427.

参考文献

[1] Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424.
[2] Ferlay J, Ervik M, Lam F, et al.Global Cancer Observatory: Cancer Today[DB/OL]. Lyon, France: International Agency for Research on Cancer.[2019-8-1]. https://gco.iarc.fr/today.
[3] 孙可欣, 郑荣寿, 张思维, 等. 2015年中国分地区恶性肿瘤发病和死亡分析[J/OL]. 中国肿瘤. [2019-9-1].http://kns.cnki.net/kcms/detail/11.2859.R.20190107.1049.006.html
[4] 高玉堂, 卢伟. 上海市区恶性肿瘤发病率、死亡率和生存率(1973-2000)[M]. 上海: 第二军医大学出版社,2007:Ⅳ-Ⅴ.
[5] 上海市疾病预防控制中心. 上海市恶性肿瘤发病率、死亡率和生存率(2001-2012)[M]. 上海:上海科学普及出版社,2017:1-6.
[6] 全国肿瘤防治研究办公室, 卫生部卫生统计信息中心, 全国肿瘤登记中心. 中国肿瘤登记工作指导手册[M]. 北京:中国协和医科大学出版社,2004.
[7] 卢伟, 郑莹. 肿瘤命名与编码[M]. 上海: 第二军医大学出版社,2011.
[8] Ferlay J, Colombet M, Soerjomataram I, et al.Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer,2019, 144(8):1941-1953.
[9] Parkin DM, Chen VW, Ferlay J, et al.Comparability and quality control in cancer registration. IARC Technical Report No 19[M]. Lyon: IARC Press,1994.
[10] Tavassoli FA, Devilee P.World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs[M]. Lyon: IARC Press,2003:10.
[11] Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods[M]. Lyon: IARC Scientific Publications,1991.
[12] Segi M.Cancer mortality for selected sites in 24 countries (1950-1957)[D]. Sendai, Japan: Tohoku University School of Medicine,1960.
[13] Joinpoint Regression Program, Version 4.7.0.0[CP]. Statistical Research and Applications Branch, National Cancer Institute,2019.
[14] Kim HJ, Fay MP, Feuer EJ, et al.Permutation tests for joinpoint regression with applications to cancer rates[J]. Stat Med,2000,19(3):335-351.
[15] Bernard WS, Christopher PW.World Cancer Report 2014[EB]. Lyon: WHO Press,2014:362-373.
[16] 陈万青, 郑荣寿. 中国女性乳腺癌发病死亡和生存状况[J]. 中国肿瘤临床,2015,42(13):668-674.
[17] 黄哲宙, 陈万青, 吴春晓, 等. 中国女性乳腺癌的发病和死亡现况——全国32个肿瘤登记点2003-2007年资料分析报告[J]. 肿瘤,2012,32(6):435-439.
[18] 郑莹, 李德錄, 向泳梅, 等. 上海市区乳腺癌流行现状及趋势分析[J]. 外科理论与实践,2001,6(4):219-221.
[19] 黄哲宙, 陈万青, 吴春晓, 等. 北京、上海、林州和启东地区女性乳腺癌发病及死亡的时间趋势[J]. 肿瘤,2012,32(8):605-608.
[20] 吴春晓, 郑莹, 鲍萍萍, 等. 2003—2012年上海市户籍女性乳腺癌发病特征分析[J]. 中华预防医学杂志,2017,51(8):692-697.
[21] 鲍萍萍, 龚杨明, 彭鹏, 等. 2014年上海市恶性肿瘤发病和死亡特征分析[J]. 中国癌症杂志,2018,28(3):161-176.
[22] 鲍萍萍, 吴春晓, 张敏璐, 等. 2015年上海市恶性肿瘤流行特征分析[J]. 中国癌症杂志,2019,29(2):6-24.
[23] Parkin DM.Global cancer statistics in the year 2000[J]. Lancet Oncol,2001,2(9):533-543.
[24] 郑莹, 吴春晓, 张敏璐. 乳腺癌在中国的流行状况和疾病特征[J]. 中国癌症杂志,2013,23(8):561-569.
[25] Vineis P, Wild CP.Global cancer patterns: causes and prevention[J]. Lancet,2014,383(9916):549-557.
[26] Torre LA, Bray F, Siegel RL, et al.Global Cancer Statistics, 2012[J]. CA Cancer J Clin,2015,65(2):87-108.
[27] Levi F, Randimbison L, Te VC, et al.Incidence of breast cancer in women with fibroadenoma[J]. Int J Cancer,1994,57(5):681-683.
[28] London SL, Connolly JL, Schnitt SJ, et al.A prospective study of benign breast disease and the risk of breast cancer[J]. JAMA,1992,267(7):941-944.
[29] Surveillance, Epidemiology,End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2017 Sub (1973-2015 varying) - Linked To County Attributes - Total U.S., 1969-2016 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2018, based on the November 2017 submission[DB]. [2019-9-2].End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2017 Sub (1973-2015 varying) - Linked To County Attributes - Total U.S., 1969-2016 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2018, based on the November 2017 submission[DB]. [2019-9-2].http:// www.seer.cancer.gov.